Go to contents
Go to menu

SITE LINK

Clinical and Molecular Hepatology Search Results : 15

SELECT ALL


1 Clinical and serological prognostic markers in primary biliary cholangitis Wilhelmi Markus Clinical and Molecular Hepatology 2021 Volume.27 No.2 360 ~ 361
2 Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treat... Song Do-Seon Kim Won, Ahn Sang-Hoon, Yim Hyung-Joon, Jang Jae-Young, Kweon Young-Oh, Cho Yong-Kyun, Kim... Clinical and Molecular Hepatology 2021 Volume.27 No.2 346 ~ 359
3 Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatiti... Xu Gang Wang Yu-Min, Ying Miao-Miao, Chen Sui-Dan, Li Zong-Rui, Ma Hong-Lei, Zheng Ming-Hua, Wu Ji... Clinical and Molecular Hepatology 2021 Volume.27 No.2 329 ~ 345
4 Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prog... Lin Ching-Chih Liu Ta-Wei, Yeh Ming-Lun, Tsai Yi-Shan, Tsai Pei-Chien, Huang Chung-Feng, Huang Jee-Fu, Ch... Clinical and Molecular Hepatology 2021 Volume.27 No.2 313 ~ 328
5 Direct comparison of biopsy techniques for hepatic malignancies Huang Shang-Chin Liang Ja-Der, Hsu Shih-Jer, Hong Tzu-Chan, Yang Hung-Chih, Kao Jia-Horng Clinical and Molecular Hepatology 2021 Volume.27 No.2 305 ~ 312
6 Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for pati... Jeon Mi-Young Kim Beom-Kyung, Lee Jae-Seung, Lee Hye-Won, Park Jun-Yong, Kim Do-Young, Ahn Sang-Hoon, Ha... Clinical and Molecular Hepatology 2021 Volume.27 No.2 295 ~ 304
7 Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort s... Jang Suk-Yong Rou Woo-Sun, Kim Seok-Hyun, Lee Byung-Seok, Eun Hyuk-Soo Clinical and Molecular Hepatology 2021 Volume.27 No.2 283 ~ 294
8 Another oral antiviral treatment, but still far away from hepatitis B virus cure Tseng Tai-Chung Clinical and Molecular Hepatology 2021 Volume.27 No.2 281 ~ 282
9 Biopsy or cytology for diagnosing hepatic focal lesions? Kim Hae-Ryoung Clinical and Molecular Hepatology 2021 Volume.27 No.2 278 ~ 280
10 Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase... Yip Terry Cheuk-Fung Wong Grace Lai-Hung, Wong Vincent Wai-Sun Clinical and Molecular Hepatology 2021 Volume.27 No.2 273 ~ 277
11 A need for patient-centered care in managing patients with liver cirrhosis Yoon Eileen L. Clinical and Molecular Hepatology 2021 Volume.27 No.2 270 ~ 272
12 From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or rippl... Kang Seong-Hee Cho Yu-Ri, Jeong Soung-Won, Kim Seung-Up, Lee Jin-Woo Clinical and Molecular Hepatology 2021 Volume.27 No.2 257 ~ 269
13 Current and future strategies for the treatment of chronic hepatitis C Alshuwaykh Omar Kwo Paul Y. Clinical and Molecular Hepatology 2021 Volume.27 No.2 246 ~ 256
14 Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospec... Torimura Takuji Iwamoto Hideki Clinical and Molecular Hepatology 2021 Volume.27 No.2 236 ~ 245
15 Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease Wijarnpreecha Karn Aby Elizabeth S., Ahmed Aijaz, Kim Dong-Hee Clinical and Molecular Hepatology 2021 Volume.27 No.2 221 ~ 235

site infomation

Prohibition of Unauthorized Collection of E-mail Addresses, medric.kyung@gmail.com
N4 301, Chungbuk National University, Chungdae-ro 1, Seowon-Gu, Cheongju, Chungbuk 28644, Korea